Core Viewpoint - A class action lawsuit has been filed against XPLR Infrastructure, LP (formerly Nextera Energy Partners, LP) for misleading statements made during the Class Period from September 27, 2023, to January 27, 2025, potentially affecting investors' rights and financial interests [1][5]. Group 1: Lawsuit Details - The lawsuit claims that XPLR was struggling to maintain its operations as a yieldco, which focuses on delivering cash distributions to investors [5]. - Defendants allegedly made false statements and failed to disclose significant risks associated with financing arrangements that temporarily alleviated operational issues [5]. - The lawsuit asserts that XPLR's business model and distribution growth rate were unsustainable, leading to planned halts in cash distributions to investors [5]. Group 2: Investor Actions - Investors who purchased XPLR common units during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested investors can join the class action by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must be appointed by September 8, 2025, to represent the class in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements for investors, including over $438 million in 2019 [4]. - The firm has been recognized for its leadership in securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Lockheed Martin securities between January 23, 2024, and July 21, 2025, about the upcoming lead plaintiff deadline on September 26, 2025 [1]. Group 1: Class Action Details - Investors who bought Lockheed Martin securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by September 26, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Allegations Against Lockheed Martin - The lawsuit alleges that Lockheed Martin made false and misleading statements and failed to disclose critical information regarding its internal controls and risk management practices [5]. - Specific claims include the lack of effective internal controls over risk-adjusted contracts, inaccurate program reviews, and overstated capabilities in meeting contract commitments [5]. - As a result of these alleged misrepresentations, the lawsuit claims that investors suffered damages when the true information became public [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased iRobot Corporation securities during the specified Class Period of the upcoming lead plaintiff deadline on September 5, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought iRobot securities between January 29, 2024, and March 11, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by the September 5, 2025 deadline [2]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering hundreds of millions for investors [3]. - The firm achieved the largest securities class action settlement against a Chinese company at the time and has consistently ranked among the top firms for securities class action settlements since 2013 [3]. Group 3: Case Allegations - The lawsuit alleges that iRobot made false and misleading statements regarding its Restructuring Plan and its ability to operate profitably as a standalone company after the termination of the Amazon Acquisition [4]. - It is claimed that there was substantial doubt about iRobot's ability to continue as a going concern, and that the defendants' public statements were materially false and misleading throughout the Class Period [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Neogen Corporation common stock between January 5, 2023, and June 3, 2025, of the September 16, 2025, deadline to become lead plaintiffs in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Neogen common stock during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [2][5] - The lead plaintiff must file a motion with the court by September 16, 2025, to represent other class members [2] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3] - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3] - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, and many attorneys at the firm have received accolades from Lawdragon and Super Lawyers [3] Group 3: Case Allegations - The lawsuit alleges that Neogen's defendants made false and misleading statements about the integration process, claiming it was progressing smoothly when it was not [4] - Initially, defendants stated that the integration was "off to a great start" and that Neogen was experiencing solid core growth and profitability [4] - Despite acknowledging certain "inefficiencies" during the integration, defendants downplayed these issues, leading to investor damages when the true situation was revealed [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Fiserv, Inc. common stock between July 24, 2024, and July 22, 2025, of the September 22, 2025, deadline to serve as lead plaintiff in a class action lawsuit [1][2] Group 1: Class Action Details - A class action lawsuit has been filed against Fiserv, and investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1][2] - To join the class action, investors can submit a form or contact the law firm for more information [2][5] - The lawsuit claims that Fiserv made false and misleading statements regarding its Clover platform and the forced migration of Payeezy merchants, which concealed a slowdown in new merchant business [4] Group 2: Allegations Against Fiserv - The lawsuit alleges that Fiserv's Clover platform experienced temporary revenue growth due to forced conversions from the Payeezy platform, masking underlying issues [4] - It is claimed that many former Payeezy merchants switched to competing solutions due to Clover's high pricing and compatibility issues, leading to a significant slowdown in Clover's growth [4] - The lawsuit asserts that Fiserv's positive statements about Clover's growth strategies and business prospects were materially false and misleading [4] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3] - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3] - Founding partner Laurence Rosen has been recognized as a Titan of Plaintiffs' Bar by Law360, and many attorneys at the firm have received accolades from Lawdragon and Super Lawyers [3]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Flywire Corporation securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][5]. Group 1: Class Action Details - Investors who bought Flywire securities between February 28, 2024, and February 25, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by September 23, 2025 [3]. - The lawsuit alleges that Flywire's management made false and misleading statements regarding the sustainability of revenue growth and the impact of permit and visa-related restrictions on the business [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise in this area [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Centene Corporation securities between December 12, 2024, and June 30, 2025, of the September 8, 2025, deadline to become lead plaintiffs in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Centene securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by September 8, 2025, to serve as lead plaintiff [2] - The lawsuit alleges that Centene's management provided misleading information regarding the company's revenue guidance and earnings per share for the 2025 fiscal year, while concealing adverse facts about enrollment and morbidity rates [4] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [3] - The firm has secured significant settlements for investors, including over $438 million in 2019 and has been ranked highly for its performance in securities class action settlements [3]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Luminar Technologies, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on September 22, 2025 [1]. Group 1: Class Action Details - Investors who purchased Luminar securities between March 20, 2025, and May 14, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting the law firm or visiting their website [3][6]. - The lawsuit claims that Luminar's executives made false and misleading statements, which led to investor damages when the truth was revealed [5]. Group 2: Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own success in recovering significant amounts for investors [4]. - The firm has been recognized for its achievements in securities class action settlements, including a notable settlement of over $438 million in 2019 [4]. Group 3: Case Specifics - The lawsuit alleges that Luminar's President, CEO, and Chairman, Austin Russell, was involved in undisclosed conduct that posed risks to his position and the company's business operations [5]. - The negative implications of Russell's potential departure could adversely affect Luminar's competitive standing, R&D management, and customer relationships [5].

Core Viewpoint - A class action lawsuit has been filed against Novo Nordisk A/S for allegedly providing misleading statements regarding its growth potential and market capabilities during the specified class period from May 7, 2025, to July 28, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Novo Nordisk made overly positive statements while concealing material adverse facts about its growth potential, particularly regarding the GLP-1 market [5]. - It is alleged that the company overstated the likelihood of patients switching to its branded alternatives and misrepresented its capability to penetrate the GLP-1 market [5]. - Investors are encouraged to join the class action to seek compensation without upfront costs through a contingency fee arrangement [2][3]. Group 2: Legal Representation - The Rosen Law Firm, known for its success in securities class actions, is representing the investors and has a strong track record in recovering significant amounts for clients [4]. - Investors are advised to select qualified legal counsel with a proven history in similar cases, as not all firms have comparable experience [4]. Group 3: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - It is noted that no class has been certified yet, and investors may choose to remain absent or select their own counsel [7].

Financial Data and Key Metrics Changes - Software revenue in Q2 was $32,700,000, up 12% year over year, while total revenue was $38,100,000, up 6% year over year [6][26] - Adjusted EBITDA for Q2 was negative $2,700,000, representing an adjusted EBITDA margin of negative 7%, which is a $2,000,000 improvement over the previous year [7][30] - The company ended Q2 with $114,500,000 in cash and short-term investments and no debt [7][31] - Net loss in Q2 was $2,800,000, or negative 7% of revenue, compared to a net loss of $4,400,000, or negative 12% of revenue in Q2 of the prior year [31] Business Line Data and Key Metrics Changes - Services revenues, including DISCO Manager Review and professional services, were $5,400,000, with softness noted in the review business but optimism for growth in auto review [28] - The company saw strong growth stemming from net new usage on the platform and expansion of multi-terabyte matters [26][28] Market Data and Key Metrics Changes - The company ended Q2 with 323 customers who each contributed more than $100,000 in total revenue over the last twelve months, up 6% year over year [8][51] - The growth of multi-terabyte matters is a significant driver of revenue, with larger matters providing longer revenue streams and better predictability [50][51] Company Strategy and Development Direction - The company is focused on targeting customers with larger eDiscovery wallets and larger matters, which is starting to pay off [7][8] - The "With You In Every Case" initiative aims to support customers with complex cases, enhancing the value proposition and driving software revenue growth [10][11] - The company is investing in customer success and sales enablement to support its growth strategy [43][44] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, highlighting the early impact of strategic initiatives and the potential for sustainable growth [78][79] - The company aims to achieve adjusted EBITDA breakeven in 2026, with a focus on operational prudence and revenue growth [41][44] Other Important Information - The CFO announced plans to step down at the end of the year, with a search for a successor already initiated [24] - The company is seeing strong interest in its AI capabilities, particularly in the EU and UK markets [17][19] Q&A Session Summary Question: Is the "With You in Every Case" initiative aimed at new customer acquisition or expansion within existing customers? - Management clarified that the initiative is about supporting customers with their largest and most complex cases, which has led to increased software revenue through better education about service capabilities [34][36] Question: Will achieving EBITDA targets hinge more on revenue growth or operational prudence? - Management stated that the goal is to be adjusted EBITDA positive or breakeven in 2026, with a focus on reallocating expenses to drive growth [40][41] Question: How does moving upmarket into larger matters increase revenue visibility? - Management noted that larger matters tend to last longer and come from larger customers, providing better predictability and opportunities for expansion [49][50] Question: What is the revenue uplift from the Cecilia product? - While specific numbers were not disclosed, management expressed satisfaction with the adoption and revenue associated with Cecilia, particularly in larger multi-terabyte matters [52][54] Question: What changes have been made to the lead generation team? - The lead generation team has shifted from merely setting up meetings to a more orchestrated approach, focusing on existing accounts and expanding wallet share [63][66]